almotriptan has been researched along with topiramate in 3 studies
Studies (almotriptan) | Trials (almotriptan) | Recent Studies (post-2010) (almotriptan) | Studies (topiramate) | Trials (topiramate) | Recent Studies (post-2010) (topiramate) |
---|---|---|---|---|---|
188 | 59 | 42 | 3,197 | 557 | 1,329 |
Protein | Taxonomy | almotriptan (IC50) | topiramate (IC50) |
---|---|---|---|
Carbonic anhydrase 1 | Homo sapiens (human) | 0.25 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.8683 | |
Carbonic anhydrase 2 | Rattus norvegicus (Norway rat) | 1.4 | |
Carbonic anhydrase 4 | Bos taurus (cattle) | 0.054 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bermejo, PE; Dorado, R; Gomez-Arguelles, JM | 1 |
1 review(s) available for almotriptan and topiramate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for almotriptan and topiramate
Article | Year |
---|---|
Variation in almotriptan effectiveness according to different prophylactic treatments.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Drug Interactions; Drug Therapy, Combination; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Propranolol; Serotonin Receptor Agonists; Topiramate; Treatment Outcome; Tryptamines; Young Adult | 2009 |
1 other study(ies) available for almotriptan and topiramate
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |